Role of abatacept in the prevention of graft-

abatacept allogeneic hematopoietic stem cell transplantation graft-versus-host disease

Journal

Therapeutic advances in hematology
ISSN: 2040-6207
Titre abrégé: Ther Adv Hematol
Pays: England
ID NLM: 101549589

Informations de publication

Date de publication:
2023
Historique:
received: 06 04 2022
accepted: 28 11 2022
entrez: 27 2 2023
pubmed: 28 2 2023
medline: 28 2 2023
Statut: epublish

Résumé

Administration of abatacept following transplantation has been reported to inhibit graft rejection and graft-

Identifiants

pubmed: 36845849
doi: 10.1177/20406207231152644
pii: 10.1177_20406207231152644
pmc: PMC9943961
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

20406207231152644

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

© The Author(s), 2023.

Déclaration de conflit d'intérêts

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

J Immunol. 1996 Nov 1;157(9):4258-67
pubmed: 8892665
Transplantation. 2021 Apr 1;105(4):891-896
pubmed: 32467478
J Clin Immunol. 2011 Aug;31(4):588-95
pubmed: 21487894
Blood Adv. 2020 Aug 25;4(16):3894-3899
pubmed: 32813873
J Clin Oncol. 2021 Jun 10;39(17):1865-1877
pubmed: 33449816
Blood. 1994 Jun 15;83(12):3815-25
pubmed: 7515723
BMC Immunol. 2013 Aug 05;14:34
pubmed: 23915385
Exp Hematol. 2001 Apr;29(4):534-41
pubmed: 11301194
Leuk Lymphoma. 2013 Aug;54(8):1591-601
pubmed: 23278640
Ann Hematol. 2021 Mar;100(3):779-787
pubmed: 33515310
Biol Blood Marrow Transplant. 2013 Nov;19(11):1638-49
pubmed: 24047754
Bone Marrow Res. 2011;2011:976793
pubmed: 22046574
Blood. 2010 Dec 9;116(24):5403-18
pubmed: 20833977
Clin Exp Immunol. 2014 Sep;177(3):630-40
pubmed: 24773026
Transplantation. 1994 Sep 15;58(5):602-10
pubmed: 8091487
Front Oncol. 2021 Aug 20;11:717678
pubmed: 34490116
Bone Marrow Transplant. 2021 Mar;56(3):586-595
pubmed: 32968215
Blood. 1999 Oct 1;94(7):2523-9
pubmed: 10498626
Bone Marrow Transplant. 2020 Jun;55(6):1093-1102
pubmed: 31969678
Ther Adv Hematol. 2013 Oct;4(5):335-44
pubmed: 24082994
Nat Rev Immunol. 2002 Jun;2(6):439-46
pubmed: 12093010
Nat Rev Drug Discov. 2006 Mar;5(3):185-6
pubmed: 16557658
Isr Med Assoc J. 2017 Jul;19(7):406-410
pubmed: 28786253
Br J Haematol. 2019 Dec;187(5):563-572
pubmed: 31588560
Blood Adv. 2022 Feb 8;6(3):746-749
pubmed: 34753172
Cancer Treat Res. 2009;144:1-21
pubmed: 19779888
Blood. 2018 Jun 21;131(25):2836-2845
pubmed: 29549175
Nat Rev Immunol. 2001 Dec;1(3):220-8
pubmed: 11905831
Bone Marrow Transplant. 2000 Feb;25(4):411-7
pubmed: 10723585
Nat Med. 2000 Apr;6(4):464-9
pubmed: 10742157
Rheumatology (Oxford). 2016 Apr;55(4):710-20
pubmed: 26672908
Biol Blood Marrow Transplant. 2020 Aug;26(8):1469-1476
pubmed: 32428732
N Engl J Med. 2007 Oct 11;357(15):1472-5
pubmed: 17928594
Transpl Immunol. 2017 Aug;43-44:54-59
pubmed: 28802588
Blood Rev. 2021 Jul;48:100792
pubmed: 33386151
Blood. 2002 Mar 1;99(5):1840-9
pubmed: 11861303

Auteurs

Alexander Ngwube (A)

Center for Cancer and Blood Disorders, Phoenix Children's Hospital, 1919 East Thomas Road, Phoenix, AZ 85016-7710, USA.

Hemalatha Rangarajan (H)

Division of Pediatric Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital, Columbus, OH, USA.

Niketa Shah (N)

Section of Pediatric Hematology Oncology and Bone Marrow transplant, Yale School of Medicine, New Haven, CT, USA.

Classifications MeSH